{"id":"https://openalex.org/W7225397887","doi":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","title":"HER2-positive Colorectal Cancer: Molecular Biology, Clinical Significance, and Therapeutic Implications with an Emphasis on Metastatic Disease","display_name":"HER2-positive Colorectal Cancer: Molecular Biology, Clinical Significance, and Therapeutic Implications with an Emphasis on Metastatic Disease","publication_year":2026,"publication_date":"2026-11-06","ids":{"openalex":"https://openalex.org/W7225397887","doi":"https://doi.org/10.4274/ijgcr.galenos.2026.79653"},"language":"en","primary_location":{"id":"doi:10.4274/ijgcr.galenos.2026.79653","doi":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","is_oa":true,"landing_page_url":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","pdf_url":"https://gicancerjournal.com/pdf/87bf8cdb-e327-4a57-b2b5-56e4c99c141f/articles/IJGCR.galenos.2026.79653/65-79.pdf","source":{"id":"https://openalex.org/S7407122253","display_name":"International Journal of Gastrointestinal Cancer Research","issn_l":"3149-997X","issn":["3149-997X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gastrointestinal Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://gicancerjournal.com/pdf/87bf8cdb-e327-4a57-b2b5-56e4c99c141f/articles/IJGCR.galenos.2026.79653/65-79.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071758726","display_name":"Ye\u015fim YILDIRIM","orcid":"https://orcid.org/0000-0001-9114-8091","observed_orcids":["https://orcid.org/0000-0001-9114-8091"]},"institutions":[{"id":"https://openalex.org/I25010766","display_name":"Hali\u00e7 University","ror":"https://ror.org/022xhck05","country_code":"TR","type":"education","lineage":["https://openalex.org/I25010766"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Ye\u015fim Y\u0131ld\u0131r\u0131m","raw_affiliation_strings":["Hali\u00e7 University Faculty of Medicine , Depertment Internal Medicine , Division of Medical Oncology , \u0130stanbul , T\u00fcrkiye","Hali\u00e7 University Faculty of Medicine , Division of Medical Oncology , Depertment Internal Medicine , \u0130stanbul , T\u00fcrkiye"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hali\u00e7 University Faculty of Medicine , Depertment Internal Medicine , Division of Medical Oncology , \u0130stanbul , T\u00fcrkiye","institution_ids":["https://openalex.org/I25010766"]},{"raw_affiliation_string":"Hali\u00e7 University Faculty of Medicine , Division of Medical Oncology , Depertment Internal Medicine , \u0130stanbul , T\u00fcrkiye","institution_ids":["https://openalex.org/I25010766"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5071758726"],"corresponding_institution_ids":["https://openalex.org/I25010766"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"65","last_page":"79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8144999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.8144999742507935,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.1793999969959259,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-colorectal-cancer","display_name":"HER2-positive colorectal cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/erbb2-amplification","display_name":"ERBB2 amplification","score":0.8640000224113464},{"id":"https://openalex.org/keywords/erbb2-mutations","display_name":"ERBB2 mutations","score":0.9269999861717224},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.9860000014305115},{"id":"https://openalex.org/keywords/her2-testing","display_name":"HER2 testing","score":0.6549999713897705},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.875},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9110000133514404},{"id":"https://openalex.org/keywords/tucatinib","display_name":"tucatinib","score":0.9819999933242798},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.996999979019165},{"id":"https://openalex.org/keywords/anti-egfr-resistance","display_name":"anti-EGFR resistance","score":0.800000011920929},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.7710000276565552},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/her2-blockade","display_name":"HER2 blockade","score":0.5320000052452087},{"id":"https://openalex.org/keywords/resistance-mechanisms","display_name":"resistance mechanisms","score":0.45899999141693115},{"id":"https://openalex.org/keywords/microsatellite-stability","display_name":"microsatellite stable","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8183000087738037},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5985000133514404},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5092999935150146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4975999891757965},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3944000005722046},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3082999885082245},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.29429998993873596},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.27900001406669617},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25929999351501465},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4274/ijgcr.galenos.2026.79653","doi":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","is_oa":true,"landing_page_url":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","pdf_url":"https://gicancerjournal.com/pdf/87bf8cdb-e327-4a57-b2b5-56e4c99c141f/articles/IJGCR.galenos.2026.79653/65-79.pdf","source":{"id":"https://openalex.org/S7407122253","display_name":"International Journal of Gastrointestinal Cancer Research","issn_l":"3149-997X","issn":["3149-997X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gastrointestinal Cancer Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4274/ijgcr.galenos.2026.79653","doi":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","is_oa":true,"landing_page_url":"https://doi.org/10.4274/ijgcr.galenos.2026.79653","pdf_url":"https://gicancerjournal.com/pdf/87bf8cdb-e327-4a57-b2b5-56e4c99c141f/articles/IJGCR.galenos.2026.79653/65-79.pdf","source":{"id":"https://openalex.org/S7407122253","display_name":"International Journal of Gastrointestinal Cancer Research","issn_l":"3149-997X","issn":["3149-997X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Gastrointestinal Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225397887.pdf","grobid_xml":"https://content.openalex.org/works/W7225397887.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3107720256","https://openalex.org/W4295539591","https://openalex.org/W4309658417","https://openalex.org/W6991489724","https://openalex.org/W4280492853","https://openalex.org/W4409787072","https://openalex.org/W4400920160","https://openalex.org/W4400044751","https://openalex.org/W4413254537","https://openalex.org/W4401322847"],"abstract_inverted_index":{"Human":[0],"epidermal":[1],"growth":[2,101],"factor":[3,102],"receptor":[4,103],"2":[5],"(HER2),":[6],"the":[7,11,41,57,65,205,251,291],"protein":[8,69,86],"product":[9],"of":[10,30,44,59,67,231,254],"ERBB2":[12,60,126,129],"gene,":[13],"is":[14,48,107,137],"an":[15,159,245,285],"emerging":[16],"therapeutic":[17,224,247,270],"target":[18,248],"in":[19,26,33,109,144,151,184,198,209,249,275],"colorectal":[20],"cancer":[21],"(CRC).Although":[22],"HER2":[23,68,79,141,171,267],"alterations":[24],"occur":[25],"a":[27,238],"small":[28],"proportion":[29],"CRCs,":[31],"advances":[32],"molecular":[34,72],"characterization":[35],"and":[36,51,74,78,88,94,122,128,153,180,195,218,229,258,272],"HER2-directed":[37],"therapies":[38],"have":[39],"increased":[40],"clinical":[42,53],"importance":[43],"this":[45,261],"biomarker.HER2-positive":[46],"CRC":[47,106,145],"biologically":[49,132],"heterogeneous,":[50],"its":[52],"significance":[54],"depends":[55],"on":[56,266,280],"type":[58],"alteration":[61],"(amplification":[62],"or":[63],"mutation),":[64],"level":[66],"expression,":[70],"coexisting":[71],"features,":[73],"disease":[75],"setting.ERBB2":[76],"amplification":[77],"overexpression":[80],"activate":[81],"oncogenic":[82],"pathways,":[83],"including":[84,173,201],"mitogen-activated":[85],"kinase":[87,91,114,216],"phosphoinositide":[89],"3-kinase-protein":[90],"B":[92],"signaling,":[93],"may":[95,221],"contribute":[96],"to":[97,99,283],"resistance":[98,232,243,273],"anti-epidermal":[100],"(EGFR)":[104],"therapy.HER2-positive":[105],"enriched":[108],"KRAS/NRAS/rapidly":[110],"accelerated":[111],"fibrosarcoma":[112],"B-type":[113],"(BRAF)":[115],"[rat":[116],"sarcoma":[117],"GTPase":[118],"(RAS)/BRAF]":[119],"wild-type,":[120],"left-sided,":[121],"microsatellite-stable":[123],"tumors.HER2":[124],"overexpression,":[125],"amplification,":[127],"mutation":[130],"are":[131],"distinct":[133],"alterations.Accurate":[134],"biomarker":[135,239],"assessment":[136],"therefore":[138],"essential,":[139],"although":[140,226],"testing":[142,259],"criteria":[143],"remain":[146,233],"less":[147],"standardized":[148],"than":[149],"those":[150],"breast":[152],"gastric":[154],"cancers.HER2-directed":[155],"therapy":[156],"has":[157,177,190,235],"become":[158],"established":[160],"strategy":[161],"for":[162,290],"selected":[163],"patients":[164],"with":[165,204,241,277],"previously":[166],"treated":[167],"metastatic":[168,281],"CRC.Trastuzumab-based":[169],"dual":[170],"blockade,":[172],"tucatinib":[174],"plus":[175],"trastuzumab,":[176],"demonstrated":[178],"meaningful":[179],"durable":[181],"responses,":[182],"particularly":[183],"HER2positive,":[185],"RAS":[186],"wild-type":[187],"tumors.Trastuzumab":[188],"deruxtecan":[189],"further":[191,222],"expanded":[192],"treatment":[193,256],"options":[194,257],"shown":[196],"activity":[197],"HER2-positive":[199],"tumors,":[200],"RASmutant":[202],"disease,":[203,282],"greatest":[206],"benefit":[207],"observed":[208],"immunohistochemistry":[210],"3+":[211],"tumors.Emerging":[212],"HER2-targeted":[213],"antibodies,":[214],"tyrosine":[215],"inhibitors,":[217],"antibody-drug":[219],"conjugates":[220],"broaden":[223],"options,":[225],"optimal":[227],"sequencing":[228],"mechanisms":[230,274],"uncertain.HER2":[234],"evolved":[236],"from":[237],"associated":[240],"anti-EGFR":[242],"into":[244],"actionable":[246],"CRC.Given":[250],"rapid":[252],"expansion":[253],"HER2directed":[255],"approaches,":[260],"review":[262],"synthesizes":[263],"current":[264],"evidence":[265],"biology,":[268],"testing,":[269],"strategies,":[271],"CRC,":[276],"particular":[278],"emphasis":[279],"provide":[284],"updated,":[286],"clinically":[287],"oriented":[288],"reference":[289],"field.":[292]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-11-07T00:00:00"}